The double staining for GFAP/ATRX demonstrates that reactive astrocytes retain ATRX expression in the nucleus (i.e., with ATRX-wild type), whereas in diffuse astrocytomas, tumor astrocytes are ATRX-mutant [76]. The gene discussed is ATRX; the disease is diffuse astrocytoma.